MEDICATION MANAGEMENT

What's News 6/19/2008

Alexandria, VA -- A survey conducted by the American Society of Health-System Pharmacists (ASHP) uncovered that the number of health system pharmacists playing a significant role in consulting with physicians on a wide range of drug protocols increased by 2% over the past six years.

My Campaign Platform 4/18/2008

As the Presidential campaigns heat up, there has been much talk about fixing the U.

The Dawn of a New Age 1/23/2008

According to the U.S. Census Bureau, the average life expectancy for Americans is 78 years.

Review of Select NMEs 10/18/2007

New molecular entities (NMEs), as defined by the FDA, are new drug products that have as their active ingredient a chemical substance marketed for the first time in the United States.

Seniors and Drug Development 10/18/2007

Astonishingly, it is frequently observed that the efficacy and safety of new pharmaceuticals are evaluated in patient populations with significantly different characteristics from some of the patients for whom the treatments will be prescribed in clinical practice.

New Drug Review 10/18/2007

New molecular entities (NMEs), as defined by the FDA, are new drug products that have as their active ingredient a chemical substance marketed for the first time in the United States.

New Therapies for HIV Infection 10/18/2007

Approximately 39.5 million people worldwide are infected with human immunodeficiency virus (HIV).

Pharmacy Technicians Are Valued Resources 5/18/2007

Let's face it: There isn't a pharmacist in practice that wants to make an error.

Drug Interactions in Dermatology 4/17/2007

M.

Review of Select NMEs 3/21/2007

New molecular entities (NMEs), as defined by the FDA, are new drug products that have as their active ingredient a chemical substance marketed for the first time in the United States.

Advertisement